Dr. Stanley Fahn, Director — (212) 305-5277

Clinical research involving most aspects of movement disorders: dystonia and tardive syndromes; clinical pharmacology; genetics of movement disorders; clinical and surgical trials of new therapies for Parkinson disease, dystonia and myoclonus; rating scales; and experimental therapeutics for movement disorders.

Dr. Blair Ford — (212) 305-5548

Clinical research on Parkinson disease, dystonia, tremor, Tourette syndrome and other movement disorders, including trials of new pharmacological agents, and surgical approaches to Parkinson disease and tremor.

Dr. Steven Frucht — (212) 305-5277

Clinical research in the phenomenology and experimental therapeutics of movement disorders, including Parkinson disease, myoclonus, dystonia, chorea and tics. Current projects include clinical trials of new treatments for Parkinson disease, evaluation and development of new treatments for myoclonus, and evaluation and treatment of focal task-specific dystonias, including musician’s dystonia.

Dr. Paul Greene — (212) 305-5548

Clinical phenomenology of movement disorders, experimental therapeutics for Parkinson disease, (including transplantation techniques) and botulinum toxin therapy for dystonia.

Dr. Elan D. Louis — (212) 305-5277

Clinical, epidemiological, and genetic aspects of essential tremor, Parkinson disease and Huntington disease.

Dr. Cheryl Waters — (212) 305-3665

Clinical drug trials for Parkinson disease. Clinical research on other parkinsonian syndromes and movement disorders.